Keywords Obesity, Weight loss, Bariatric surgery, Glucagon like peptide 1, Orlistat, Probiotics, Intragastric balloon, Endoscopy Introduction The relationship between diet and chronic diseases such as hypertension, diabetes, colon cancer, and obesity has undergone extensive investigation, supported by a large number of data, indicating a causal relationship between them
GLP-1 + GIP + Glucagon Receptor Activation All benefits of GLP-1 activation (appetite, fullness, insulin) GIP enhances insulin response and may reduce GLP-1 side effects Glucagon increases thermogenesis and energy expenditure Combined effect exceeds sum of individual pathways The idea of using glucagon for weight loss was considered counterintuitive until researchers discovered that glucagons metabolic effects depend heavily on the hormonal context
The modern GLP-1RA class evolved following identification of exendin-4, a GLP-1 analogue originally isolated from Gila monster venom [22]
GLP-1, PYY and other hormones spike after surgery improving insulin sensitivity and reducing the livers cholesterol output
Unfortunately, traditional glutathione capsules and tablets are notoriously difficult for the body to absorb